UnitedHealth Group Incorporated $UNH Shares Bought by Drucker Wealth 3.0 LLC

Drucker Wealth 3.0 LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 93.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,906 shares of the healthcare conglomerate’s stock after purchasing an additional 1,401 shares during the period. Drucker Wealth 3.0 LLC’s holdings in UnitedHealth Group were worth $880,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Williams & Novak LLC raised its position in shares of UnitedHealth Group by 114.4% during the 2nd quarter. Williams & Novak LLC now owns 1,441 shares of the healthcare conglomerate’s stock worth $450,000 after purchasing an additional 769 shares during the period. Aberdeen Group plc increased its position in UnitedHealth Group by 8.9% in the second quarter. Aberdeen Group plc now owns 1,281,971 shares of the healthcare conglomerate’s stock worth $398,456,000 after buying an additional 104,795 shares during the period. Pinnacle West Asset Management Inc. increased its position in UnitedHealth Group by 1.3% in the second quarter. Pinnacle West Asset Management Inc. now owns 7,210 shares of the healthcare conglomerate’s stock worth $2,249,000 after buying an additional 95 shares during the period. Agate Pass Investment Management LLC increased its holdings in shares of UnitedHealth Group by 63.2% in the 2nd quarter. Agate Pass Investment Management LLC now owns 2,758 shares of the healthcare conglomerate’s stock worth $861,000 after acquiring an additional 1,068 shares during the period. Finally, Zullo Investment Group Inc. increased its holdings in shares of UnitedHealth Group by 18.4% in the 2nd quarter. Zullo Investment Group Inc. now owns 3,984 shares of the healthcare conglomerate’s stock worth $1,243,000 after acquiring an additional 620 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Mizuho raised their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Barclays raised their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Stock Performance

Shares of UNH opened at $354.30 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.38 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm’s 50 day moving average is $318.21 and its 200-day moving average is $350.41.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.